Medication info
Diphomin 500 mg (Metformin Hydrochloride)

Diphomin 500 mg (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
White Life Science Co., Ltd.
Appearance
White round film-coated tablets
Packaging
500 tablets/bottle
Approval status
Active

MFDS item code 201403413 · Approved 2014.07.25 · Insurance code 625200660

Summary

Main use
Treatment of type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
The dose should be determined individually based on therapeutic response and tolerability, and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and determine the minimum dose needed for adequate glycemic control, this drug must be started at a low dose, with 500mg taken 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When taking up to 2000mg, the dose is generally divided and taken twice daily, in the morning and evening. For doses exceeding 2000mg, divide into 3 doses per day and take with meals; the maximum daily dose is 2550mg. When initiating treatment and adjusting the dose, measure fasting blood glucose to assess the therapeutic response to this drug and determine the minimum effective dose. Glycated hemoglobin levels should be measured approximately every 3 months. The goal of treatment with this drug, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when a patient's blood glucose, previously controlled by diet alone, becomes temporarily uncontrolled, short-term treatment with this drug may be sufficient to achieve an adequate effect. Patients with renal impairment This drug may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, using the following dose adjustments. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to below 45ml/min or 45ml/min/1.73㎡, this drug should be discontinued immediately.
Child dose
Children aged 10 years or older or adolescents who are growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Blood glucose levels should be measured after one week to adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. This dose should be divided into 2~3 administrations.

Ingredients

Manufacturer
White Life Science Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Type 2 diabetes
View approved original text

This medication is used for the treatment of patients with Type 2 diabetes who have difficulty controlling blood sugar levels with diet and exercise alone. It is particularly effective in overweight patients. In adults, it can be administered alone or in combination with other oral hypoglycemic agents or insulin. It can also be used alone or in combination with insulin for children over 10 years old and adolescents in growth. This medication helps improve blood sugar levels to assist in diabetes management.

How to take

Adult dose

The dose should be determined individually based on therapeutic response and tolerability, and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and determine the minimum dose needed for adequate glycemic control, this drug must be started at a low dose, with 500mg taken 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When taking up to 2000mg, the dose is generally divided and taken twice daily, in the morning and evening. For doses exceeding 2000mg, divide into 3 doses per day and take with meals; the maximum daily dose is 2550mg. When initiating treatment and adjusting the dose, measure fasting blood glucose to assess the therapeutic response to this drug and determine the minimum effective dose. Glycated hemoglobin levels should be measured approximately every 3 months. The goal of treatment with this drug, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when a patient's blood glucose, previously controlled by diet alone, becomes temporarily uncontrolled, short-term treatment with this drug may be sufficient to achieve an adequate effect. Patients with renal impairment This drug may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, using the following dose adjustments. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to below 45ml/min or 45ml/min/1.73㎡, this drug should be discontinued immediately.

Child dose

Children aged 10 years or older or adolescents who are growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Blood glucose levels should be measured after one week to adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. This dose should be divided into 2~3 administrations.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so caution is required. It should not be administered to patients with moderate to severe renal impairment or those with dehydration, serious infections, or cardiovascular issues. Patients who are scheduled to undergo acute heart failure or specific iodinated contrast media tests should discontinue this medication and may only resume after kidney function is confirmed to be normal post-examination. This medication is not for use in patients with hypersensitivity to this drug or similar drugs, as well as in patients with Type 1 diabetes or diabetic ketoacidosis. In cases of severe infections or major surgeries, administration should be temporarily halted, and treatment should continue only after the patient's condition stabilizes and renal function is normal. It is advisable to avoid use in patients with poor nutritional status, liver dysfunction, or pulmonary dysfunction, as well as in those who consume alcohol excessively. During pregnancy, this medication is not used if there is a risk of placental insufficiency or preeclampsia, and fetal development should be closely monitored if necessary. Renal function should be regularly monitored during treatment, especially in the elderly or those with impaired renal function. Symptoms of lactic acidosis may include malaise, muscle pain, difficulty breathing, and abdominal pain; if these occur, notify healthcare providers immediately. This medication can cause gastrointestinal disturbances, which typically occur at the initial administration but may improve over time. When used in combination with other medications that may affect blood sugar control, frequent monitoring of blood sugar levels is essential. Alcohol can increase the risk of side effects from this medication, so avoiding excessive intake during treatment is crucial. Pregnant or breastfeeding women should consult their doctor when taking this medication, and careful decisions regarding drug therapy and breastfeeding should be made during lactation. When administering to children or adolescents, the type of diabetes and the effects and side effects of the drug should be closely monitored, and adjustments in dosage may be needed for the elderly depending on renal function. In cases of overdose, blood dialysis can remove the drug, so immediate medical attention is required. This medication does not cause weight gain, aiding in weight management, but regular monitoring of blood sugar and renal function is essential. Keep out of reach of children and do not transfer to another container for safety.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • dyspepsia
  • constipation
  • abdominal pain
  • unpleasant taste
Show 8 more
  • metallic taste
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver dysfunction
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius. This helps preserve the drug's effectiveness and safety.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.